BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15488360)

  • 1. Physical inactivity: direct cost to a health plan.
    Garrett NA; Brasure M; Schmitz KH; Schultz MM; Huber MR
    Am J Prev Med; 2004 Nov; 27(4):304-9. PubMed ID: 15488360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of physical inactivity in Canada.
    Katzmarzyk PT; Gledhill N; Shephard RJ
    CMAJ; 2000 Nov; 163(11):1435-40. PubMed ID: 11192648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported health risks linked to health plan cost and age group.
    Hill RK; Thompson JW; Shaw JL; Pinidiya SD; Card-Higginson P
    Am J Prev Med; 2009 Jun; 36(6):468-74. PubMed ID: 19460654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
    Stock SA; Stollenwerk B; Redaelli M; Civello D; Lauterbach KW
    J Womens Health (Larchmt); 2008 Apr; 17(3):343-54. PubMed ID: 18338965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of community-based physical activity interventions.
    Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
    Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monthly estimates of leisure-time physical inactivity--United States, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 May; 46(18):393-7. PubMed ID: 9157273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
    Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes complications and depression as predictors of health service costs.
    Simon GE; Katon WJ; Lin EH; Ludman E; VonKorff M; Ciechanowski P; Young BA
    Gen Hosp Psychiatry; 2005; 27(5):344-51. PubMed ID: 16168795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
    Hoy T; Singhal PK; Willey VJ; Insinga RP
    Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic cost of physical inactivity in China.
    Zhang J; Chaaban J
    Prev Med; 2013 Jan; 56(1):75-8. PubMed ID: 23200874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden of physical inactivity: healthcare costs associated with cardiovascular disease.
    Oldridge NB
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):130-9. PubMed ID: 18391637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medical cost of cardiometabolic risk factor clusters in the United States.
    Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
    Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting physical activity: a profile of health plan programs and initiatives.
    Fitzner K; Madison M; Caputo N; Brown E; French M; Bondi M; Jennings C
    Manag Care Interface; 2002 Dec; 15(12):29-41. PubMed ID: 12530293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of premium, copayments, and health status on the choice of health plans.
    Naessens JM; Khan M; Shah ND; Wagie A; Pautz RA; Campbell CR
    Med Care; 2008 Oct; 46(10):1033-40. PubMed ID: 18815524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.